newsfilter
← Latest News
GlobeNewswire·

Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week

MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB:PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer today